Do Neurotrophins Connect Neurological Disorders and Heart Diseases?

Neurotrophins (NTs) are one of the most characterized neurotrophic factor family members and consist of four members in mammals. Growing evidence suggests that there is a complex inter- and bi-directional relationship between central nervous system (CNS) disorders and cardiac dysfunction, so-called...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masashi Fujitani, Yoshinori Otani, Hisao Miyajima
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/3b59aa51d3eb44d2a40bc5488e164fa6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3b59aa51d3eb44d2a40bc5488e164fa6
record_format dspace
spelling oai:doaj.org-article:3b59aa51d3eb44d2a40bc5488e164fa62021-11-25T16:54:34ZDo Neurotrophins Connect Neurological Disorders and Heart Diseases?10.3390/biom111117302218-273Xhttps://doaj.org/article/3b59aa51d3eb44d2a40bc5488e164fa62021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1730https://doaj.org/toc/2218-273XNeurotrophins (NTs) are one of the most characterized neurotrophic factor family members and consist of four members in mammals. Growing evidence suggests that there is a complex inter- and bi-directional relationship between central nervous system (CNS) disorders and cardiac dysfunction, so-called “brain–heart axis”. Recent studies suggest that CNS disorders, including neurodegenerative diseases, stroke, and depression, affect cardiovascular function via various mechanisms, such as hypothalamic–pituitary–adrenal axis augmentation. Although this brain–heart axis has been well studied in humans and mice, the involvement of NT signaling in the axis has not been fully investigated. In the first half of this review, we emphasize the importance of NTs not only in the nervous system, but also in the cardiovascular system from the embryonic stage to the adult state. In the second half, we discuss the involvement of NTs in the pathogenesis of cardiovascular diseases, and then examine whether an alteration in NTs could serve as the mediator between neurological disorders and heart dysfunction. The further investigation we propose herein could contribute to finding direct evidence for the involvement of NTs in the axis and new treatment for cardiovascular diseases.Masashi FujitaniYoshinori OtaniHisao MiyajimaMDPI AGarticleneurotrophinsnerve growth factorbrain-derived neurotrophic factortropomyosin-related kinase receptorslow-affinity p75 neurotrophin receptorbrain–heart axisMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1730, p 1730 (2021)
institution DOAJ
collection DOAJ
language EN
topic neurotrophins
nerve growth factor
brain-derived neurotrophic factor
tropomyosin-related kinase receptors
low-affinity p75 neurotrophin receptor
brain–heart axis
Microbiology
QR1-502
spellingShingle neurotrophins
nerve growth factor
brain-derived neurotrophic factor
tropomyosin-related kinase receptors
low-affinity p75 neurotrophin receptor
brain–heart axis
Microbiology
QR1-502
Masashi Fujitani
Yoshinori Otani
Hisao Miyajima
Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
description Neurotrophins (NTs) are one of the most characterized neurotrophic factor family members and consist of four members in mammals. Growing evidence suggests that there is a complex inter- and bi-directional relationship between central nervous system (CNS) disorders and cardiac dysfunction, so-called “brain–heart axis”. Recent studies suggest that CNS disorders, including neurodegenerative diseases, stroke, and depression, affect cardiovascular function via various mechanisms, such as hypothalamic–pituitary–adrenal axis augmentation. Although this brain–heart axis has been well studied in humans and mice, the involvement of NT signaling in the axis has not been fully investigated. In the first half of this review, we emphasize the importance of NTs not only in the nervous system, but also in the cardiovascular system from the embryonic stage to the adult state. In the second half, we discuss the involvement of NTs in the pathogenesis of cardiovascular diseases, and then examine whether an alteration in NTs could serve as the mediator between neurological disorders and heart dysfunction. The further investigation we propose herein could contribute to finding direct evidence for the involvement of NTs in the axis and new treatment for cardiovascular diseases.
format article
author Masashi Fujitani
Yoshinori Otani
Hisao Miyajima
author_facet Masashi Fujitani
Yoshinori Otani
Hisao Miyajima
author_sort Masashi Fujitani
title Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
title_short Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
title_full Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
title_fullStr Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
title_full_unstemmed Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
title_sort do neurotrophins connect neurological disorders and heart diseases?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/3b59aa51d3eb44d2a40bc5488e164fa6
work_keys_str_mv AT masashifujitani doneurotrophinsconnectneurologicaldisordersandheartdiseases
AT yoshinoriotani doneurotrophinsconnectneurologicaldisordersandheartdiseases
AT hisaomiyajima doneurotrophinsconnectneurologicaldisordersandheartdiseases
_version_ 1718412831670403072